Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders

Exclusion Criteria

• •Chronic intestinal disease, immunodeficiency or immunosuppressive treatment.
• •Chronic or acute diarrheal disease.
• •Use of laxatives the week before inclusion in the study.
• •Antibiotic treatment for the last four weeks before inclusion in the study.
• •Intake of probiotic products for the last two weeks before inclusion in the study.
• •Known hypersensitivity to any of the ingredients in the probiotic product or the placebo (potato starch ± bacterial culture that may contain traces of soy).
• •Patient requiring hospitalisation.